Chief Development Officer
Arsanis, Inc
David Mantus, PhD, has more than 24 years of drug development experience, including clinical, regulatory, and manufacturing successes for programs in endocrinology, central nervous disorders, and infectious diseases. His work in infectious disease product development has included small molecules, microbiome-based therapeutics, immune globulins, monoclonal antibodies, and vaccines. Dr. Mantus has led teams responsible for all aspects of product development, from pre-IND through global commercialization and partnering. Prior to Arsanis, he held leadership roles in development at Seres Health, Cubist Pharmaceuticals, Shire Biologics, PAREXEL, and Procter & Gamble Pharmaceuticals. Previously, Dr. Mantus was a Postdoctoral Research Fellow in Biomedical Engineering at the University of Washington and Associate Professor of Pharmaceutical Sciences at MCPHS University. He is co-author of a book on regulatory affairs entitled, FDA Regulatory Affairs: A Guide for Prescription Drugs, Medical Devices, and Biologics,that is currently in its third edition. Dr. Mantus received his Master of Science and PhD in Chemistry from Cornell University.
None yet.